Immunotherapy: Harnessing the Immune System to Treat Cancer

This educational activity is directed toward oncology nurses and nurse practitioners caring for patients receiving cancer immunotherapy. Learning Objectives Upon completion of this activity, the participant will be able to: 1. List the various types of immunotherapy currently used in the management of malignancies 2. Summarize the various mechanisms of action for the different immunotherapy agents 3. Describe various toxicities for specific types of immunotherapy 4. Explain specific...
Medical Learning Institute

Hematology/Oncology PICU Issues: Case Studies

Learning Objectives: Review the importance of hemoglobin, coagulation, bone marrow, fibrinolytic and transfusion issues with the critically ill child. Describe the diagnostic laboratory data necessary to care for the child with anemia, platelet disorders, and oncologic emergencies. Prioritize the care for the child with an oncologic emergency.
Contemporary Forums

Melanoma: Updates from Brisbane, Australia The latest data in melanoma reported at the joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma

Roxana S. Dronca, MD, and Lisa A. Kottschade, APRN, MSN, CNP, offer their expert insights into recent data on advanced melanoma presented at a joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research. Listen to what these experts have to say about combination therapy in the adjuvant setting for metastatic melanoma, real-world utilization of checkpoint inhibitor therapy, sequencing options for BRAF +/- MEK Inhibition following immu...
Annenberg Center for Health Sciences at Eisenhower

1st Annual Aspen Conference on Pediatric Cerebrovascular Disease and Stroke

Thought leaders in this emerging field will convene over the course of one week to share ideas, learn and create pathways to deliver cutting edge care to pediatric and young adult cerebrovascular and stroke patients.   Major Topic Areas: -Acute stroke and traumatic vascular injury: recognition and initial management -Cerebral vascular malformations (avm, aneurysms, cavernoma, vein of galen)   -Sickle cell related cerebrovascular complications -Cerebral arteriopathy of Alagille, PHACE...
Cincinnati Children's Hospital Medical Center

Contemporary Management of von Willebrand Disease in Women: Identifying Bleeding Disorders and Preventing Hemorrhage

According to the National Hemophilia Foundation, underdiagnosis of bleeding disorders in women is a significant problem. Menorrhagia associated with bleeding disorders such as von Willebrand disease (VWD) is an overlooked, undertreated, and potentially serious condition that often has a profound impact on the affected individual’s quality of life. For women with VWD, menorrhagia is almost inevitable, with prevalence ranging from 32% to as high as 100%. Lack of awareness of the high prevalenc...

28th Annual Mayo Clinic Hematology/Oncology Reviews 2018

This course is a comprehensive review of hematology/oncology that focuses on the application of new clinical and research advancements and developments over the preceding year. The most important clinical management questions in hematology/oncology will be addressed in highly interactive sessions. Attendees will leave with up-to-date, practical information which will have immediate clinical application. Attendees are encouraged to bring portable computer devices to view the syllabus on the co...
Mayo Clinic

Expert Update: What's New in Essential Thrombocythemia

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms (MPNs) to enhance clinical outcomes and patient quality of life. Recent revisions in the classification of myeloid neoplasms and acute leukemia by the World Health Organization have further defined criteria for the differential diagnosis of MPNs, including criteria for the discernment of essential thrombocythemia (ET) and prefibrotic/early primary myelofibrosis. However, many ch...
Slack Inc.

An Overview of Biosimilars: Potential Implications for Pharmacists

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). Most CSPE activities include the pathophysiology and clinical therapeutics of various disease states in which specialty pharmacy products and services are provided. CSPE also covers legal, regulatory and operational topics relevant to specialty pharmacy practice. Learning Objectives The target audience for this a...

Scale, Bail, or Fail – The CDK4/6 Inhibition Edition

Preclinical and clinical findings suggest that CDK4/6 inhibition may confer therapeutic benefits in numerous tumor types and improve outcomes in patients with mantle cell lymphoma, liposarcoma, melanoma, and non–small cell lung cancer. Additionally, studies of CDK4/6 inhibition of cancers of the prostate, lung, skin, and central nervous system are currently under way. In the format of an entertaining (but challenging!) interactive game, this edition of Scale, Bail or Fail presents and dis...
University of Cincinnati and RedMedEd

A Comprehensive Board Review in Hematology and Medical Oncology
MD Anderson

12th Northeast Regional Hematology Oncology Pharmacists Symposium

Two day conference for pharmacists and nursing specializing in hematology/oncology. • 13 contact hours offered-2 law • Network with industry professionals • Enjoy breakfast, lunch, dinner & cocktail reception • Low fee to attend- including meals: Both days: Member-$140, Non members-$160 One day: Member-$110, Non member-$125
American Health Resources, LLC

Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago

This “Ace the Case” study will utilize a case study to discuss the treatment of 48-year-old female who was diagnosed with polycythemia vera (PV) 7 years ago. Accurately assess the appropriate treatment option(s) for this patient for CME credits.
Slack Inc.

11th International Congress on Myeloproliferative Neoplasms

Since its inception 17 years ago, the International Congress on Myeloproliferative Neoplasms has provided a forum for the interaction of practicing hematologists, oncologists, translational scientists, and other healthcare professionals with experts from both the US and Europe in the myeloproliferative neoplasms, including chronic myeloid leukemia, the hyper-eosinophilic syndromes and mastocytosis. This year’s program will feature the latest information on the pathophysiology and management ...
Melton Medical Education, LLC

Mayo Clinic Pancreatic and Hepato-Biliary Cancer Symposium 2018

Nationally and internationally renowned faculty bring you a state-of-the-art update on the latest multi-disciplinary care for patients with hepato-biliary and pancreatic cancers. There will also be a focus on emerging immuno-oncology and molecular profiling options.
Mayo Clinic

The Oncologist: Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges

Learning Objectives: 1. Discuss the relevance of immunogenicity in oncology. 2. Cite the effects of anti-drug antibodies on pharmacokinetics, efficacy, and toxicity. 3. Describe challenges in the detection and interpretation of immunogenicity data. 4. Describe the potential prevention strategies in oncology. In oncology, an increasing number of targeted anticancer agents and immunotherapies are of biological origin. These biological drugs may trigger immune responses that lead to the fo...
Society For Translational Oncology

Mayo Clinic Cancer Center - Thoracic Oncology Update 2018

This course is designed for hematology oncologists, medical oncologists, radiation oncologists, surgical oncologists, oncology nurses, and healthcare professionals involved in cancer care. Also of interest to pulmonary, critical care and general internal medicine physicians who may want to enhance their thoracic oncologic knowledge.
Mayo Clinic

Mayo Clinic Cancer Center - Thoracic Oncology Update 2018

Thoracic malignancies represent the leading cause of cancer death in the United States. This continuing medical education activity will focus on recent developments in medical, surgical, radiation and medical oncologic care of patients with malignancies of the chest. The conference will emphasize recent developments in molecular pathways of carcinogenesis and immunobiology as well as novel surgical and interventional techniques. Important clinical advances and clinical trials including surgica...
Mayo Clinic

Board Vitals Hematology/Oncology CME Self-Assessment Program

Complete your Hematology/Oncology CME requirements with the Board Vitals Hematology/Oncology CME Self-Assessment Program.  • Earn 27 Hematology/Oncology CME Category 1 Credit Hours AND 27 ABIM Approved MOC Points, all while preparing for the recertification exam. • Access to more than 500 Hematology/Oncology CME questions, answers, and explanations • Each question is categorized - select the categories and areas that you want to focus on • Timed Mode and Review Mode available •...
Board Vitals

IDA in Inflammatory Bowel Disease: Pathology, Treatment Options, and the Risks of Underdiagnosis.

This activity will discuss the unique clinical relationship between inflammatory bowel disease (IBD) and iron deficiency anemia (IDA), including the role IBD pathology plays in blocking optimal iron absorption. Many IBD patients contend with multiple challenges and comorbidities that all can directly or indirectly lead to IDA and subsequent poor outcomes. A leading gastroenterologist will discuss IDA-related diagnostic challenges, treatment options, and management protocols for IBD patients. ...

IDA Pathology, Etiology, and the Role of Hepcidin Across At-Risk Patient Populations

Iron-deficiency anemia is a widespread condition affecting multiple patient populations, which can range from elderly patients and women of childbearing age to cancer patients, chronic kidney disease patients, and persons with gastroenterological conditions such as IBD, among others. IDA also affects populations not traditionally screened for iron deficiency, such as those with certain cardiovascular conditions such as congestive heart failure and cardiomyopathy. In this activity, a leading he...

Addressing Common Patient Concerns Regarding Biosimilars

As more biosimilars are approved for use in the United States, greater emphasis is needed on educating patients about their treatment options, the use of biosimilars, and shared decision-making between patients and their providers. In this CME activity, expert faculty and a patient advocate will discuss issues and concerns expressed by patients who are about to start treatment with a biosimilar product or are to be switched from an originator product to a biosimilar. The patient advocate will ...
Slack Inc.

Multiple Myeloma Expert Roundtable: Stem Cell Transplantation, Maintenance Therapy, and Relapsed/Refractory Disease

With numerous recent advances in available treatments and options for diagnosis and staging, disease monitoring, and supportive care, the outlook for patients with multiple myeloma has never been brighter. However, this expansion of clinical options has also introduced potentially daunting challenges for the health care providers charged with the care of these patients. This activity presents a robust roundtable discussion in which our expert faculty provides insights on such issues as dete...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Multiple Myeloma Expert Roundtable: Risk Assessment, Minimal Residual Disease, and Precision Medicine

The clinical multiple myeloma arena has undergone significant advancement in recent years; not only have 10 drugs been added to the armamentarium, but there have been important developments in diagnosis and staging, minimal residual disease (MRD) monitoring, and supportive care. The expansion of clinical options brings both opportunities and challenges for health care providers who see myeloma patients. In this roundtable, our expert panel discusses the newest evidence regarding the identif...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

MKSAP 17 Audio Companion Q&A: The American College of Physicians and Oakstone Program

Order this supplement to the MKSAP 17 Audio Companion and hear discussions focused on 500 MKSAP questions not covered in the main Audio Companion. It is a comprehensive Q&A that takes your learning even further and provides an opportunity to earn up to an additional 30 AMA PRA Category 1 Credits.  The MKSAP 17 Audio Companion Q&A is available only with the purchase of the 11-section Audio Companion. Topics include: Cardiovascular Medicine, Dermatology, Gastroenterology, Hepatology, Hematol...

MKSAP 17 Audio Companion: The American College of Physicians Program

The MKSAP 17 Audio Companion is made up of audio interviews with expert contributors from the country's leading medical facilities and teaching institutions. Listening to the MKSAP 17 Audio Companion helps to prepare you for ABIM certification or maintenance of certification. Topics include: Cardiovascular Medicine, Dermatology, Gastroenterology, Hepatology, Hematology, Oncology, Neurology, Rheumatology and the full range of internal medicine subjects.

Ace the Case: A 70-Year-Old Woman with Cough and a Lung Mass

This “Ace the Case” activity will discuss the diagnosis and management of a 70-year-old woman with cough and a lung mass on CT scan.
Slack Inc.

EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of all cancer-related deaths. In 2018, it is estimated that 234,030 new cases of lung cancer, of which 85% will be non-small cell lung cancer (NSCLC), and 154,050 lung cancer-related deaths will be reported. The identification of underlying oncogenic drivers in NSCLC and the utilization of mutational analysis for diagnosis as well as appropriate therapy selection have led to a t...
Slack Inc.

Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients diagnosed with HCC is challenging, as tumor stage and potential underlying liver disease must be considered prior to initiation of therapy. If detected early, surgical resection or liver transplantation are curative options; however, most HCC cases are diagnosed at an advanced stage. For patients with advanced disease, systemic therapy with targeted agents has demonstrated prolong...
Slack Inc.

Applying Advances with Checkpoint Inhibitors in Thoracic Oncology

Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung cancer will occur in the United States in 2018, resulting in 155,870 deaths. Mesothelioma, a cancer that can develop in the lining of the lungs, is commonly caused by exposure to asbestos and is associated with a poor prognosis. Advances in lung cancer treatment, including the introduction of immune checkpoint inhibitors, are increasing the number of patients who receive treatment ...
Slack Inc.

Treatment Strategies in Chronic Leukemias and Introduction to CAR-T Therapy

Chronic lymphocytic (CLL) and chronic myelogenous (CML) leukemia are commonly diagnosed and treated by community oncologists. Whereas, in the past, these hematologic malignancies were considered incurable, new therapies have challenged that notion. Tyrosine kinase inhibitors (TKIs) annihilated the concept of CML as a poorly controlled disease, and most patients are now expected to live a normal life, with good quality of life. New testing procedures have suggested that some patients may be ...
Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology

Payment Models and Practice Changes: Meeting Requirements of OCM & MACRA

Recent legislation and policy has fast-tracked the shift of healthcare payment from volume- to value-based reimbursement under the Medicare Access and CHIP Reauthorization Act (MACRA) for oncology care. Today, oncologists have the option to be reimbursed for Medicare patients under the CMS Oncology Care Model (OCM), an alternative payment model spanning a 6-month chemotherapy episode-of-care. This activity will provide insight into the program’s structure and challenges. It will also review ...
Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology

Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care

Improving outcomes for patients with multiple myeloma requires building on the foundation of current therapies with new agents and combinations, recognizing the nature of each individual patient’s disease, and providing a personalized approach to treatment. This activity uses evidence-based presentations and case study vignettes to present the latest information on selecting the most appropriate therapy based on patient profile, clinical evidence, and assessment of risk-versus-benefit. Le...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Significant advances in treatment with novel agents for B-cell non-Hodgkin’s lymphoma (NHL) have improved patient outcomes and survival. However, many patients are at high-risk of relapse, meriting a precision approach to reduce the rate of recurrence and improve outcomes. The identification of molecular subtypes, the persistence of clinical challenges, and the anticipated emergence of clinical data necessitate a collaborative treatment approach to ensure individualized care for patients wit...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers

The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis of recent clinical studies have demonstrated that colorectal cancers with mismatch repair deficiency (dMMR) and other advanced dMMR cancers are sensitive to immune checkpoint blockade with PD-1 antibodies, and that mutational burden correlates with treatment response. These findings have led to the recent approval of two immune checkpoint inhibitors for the treatment of micro...
Slack Inc.

Navigating New Options to Improve Outcomes in Multiple Myeloma

As new combinations and classes of agents emerge for the treatment of multiple myeloma (MM), community-based treatment teams require clarity on the optimal integration of recently approved and emerging agents into the relapsed/refractory landscape for MM. While high-dose chemotherapy is not appropriate for all patients, multiple options have emerged that demonstrate a clinical benefit and require proper integration into the treatment paradigm. In addition, clinicians must meet requirements for...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Targeted Therapy for Skin Malignancies: Basal Cell Carcinoma, Melanoma, and Merkel Cell

Patients may not always be offered the most appropriate single and combination targeted therapies that have been proven effective in clinical trials. Currently available clinical data have practice-changing implications for medical oncologists, dermatologists, and related specialists treating skin malignancies. To stay up to date with the latest data, evidence will be presented related to the role of BRAF inhibition, hedgehog signaling, and immunotherapy in the pathogenesis and treatment of ba...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Advancing Standards in the Management of Hemophilia A: Contemporary Strategies and Innovations

The US health care ecosystem has undergone a profound transformation in recent years, with far-reaching implications for patients with hemophilia A. Clinical management of patients with hemophilia has become increasingly complex due to the introduction of new treatment strategies, the presence of comorbidities related to hemophilia, and the increased emphasis on outcomes such as quality of life, to balance both the medical and lifestyle consequences of the disease. Patients with severe hemophi...

Precision Medicine and Impact of Therapeutic Drug Levels

Much has been written recently about the need for genetic testing and biomarkers to identify specific targets within cancers, recognizing that there are many subclones and individual differences within the malignancies that arise in patients, even in those with morphologically similar cancers. Another important aspect of cancer treatment is the need to optimize the dose and schedule of administered therapies. Pharmacogenomics has demonstrated that the bioavailability and half-lives of anti-ca...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Targeting EGFR, T790M, ALK, and ROS1 in NSCLC

Oncology treatment teams are tasked with navigating through a steady increase in the number and complexity of molecular biomarkers that guide treatment decisions. FDA-approved companion tests have expanded testing options and provide uniformity of reporting, yet challenges in the clinical setting and the potential to negatively impact patient outcomes persist. As part of the continuum of care in oncology, there is an increasing demand for genomic testing to guide the course of treatment. Misi...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing Over the Past 3 Months

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who has a brown pigmented lesion that has been changing over the past 3 months.
Slack Inc.

Rheumatic Immune-related Adverse Events: Multidisciplinary Perspectives on Recognition and Management

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new therapies are associated with a spectrum of autoimmune and systemic inflammatory reactions known as immune-related adverse events (irAEs). Rheumatologists are likely to encounter a wide variety of irAEs as the use of immune checkpoint inhibitors expands in the treatment of several cancers. Thus, it is critical for rheumatologists to be aware of these complications to accurately ...
Slack Inc.

Achieving Precision Care in Gastrointestinal Cancers

Treatment selection is largely dependent on the goals of therapy; however, sequencing of standard therapies with newly approved therapies as patients’ progress is a key factor in improving quality of care. The recent approval of new agents and advances in biomarker detection have supported the individualization of treatment and subsequent improvements in survival for patients with gastrointestinal cancers. As new agents are expected to enter the treatment paradigm in 2017, clinicians will r...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Advances in the Multidisciplinary Management of Hepatocellular Carcinoma (HCC): Strategies for Incorporating Emerging Immunotherapy Treatment Options

Expert faculty, Richard Finn, MD, discusses treatment options and strategies in a case-based approach for two patients who have failed conventional therapies and may be candidates for immunotherapy. The activity features an online virtual patient platform that affords clinicians an opportunity to absorb relevant clinical and evidence-based information. The purpose of the activity is to inform clinicians on integrating immunotherapy into treatment options of advanced hepatocellular carcinoma pa...

The Brigham Board Review in Hematology

Topics covered by The Brigham Board Review in Hematology include:  Hematopoietic Stem Cell Transplantation, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Syndromes, Hodgkin's Lymphoma, Bone Marrow Failure, Hemophagocytic Syndromes, Sickle Cell Disease, Thalassemia and many others. After completing The Brigham Board Review in Hematology, you will be able to: • Apply current/recommended Hematology guidelines in clinical practice • Perform differential diagnosis of comple...

The Brigham Board Review in Hematology and Oncology

Get ready for the ABIM exam in Hematology-Oncology by studying this Brigham Board Review in Hematology and Oncology. Topics covered by the Brigham Board Review in Hematology and Oncology include: Molecular Genetics of Cancer, Cancer Drug Development, Hematopoietic Stem Cell Transplantation, Acute Leukemias, Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin's Lymphoma, B Cell Malignancies, Mesothelioma, Thyroid Cancer and dozens of others. After completing the Brigham Board Review in Hemat...

Board Vitals Hematology and Oncology Board Review Question Bank

The Hematology and Oncology Board Review Question Bank features over 800 Hematology and Oncology questions. The Hematology Oncology exam study guide features: • Over 800 review questions and answers • The leading digital question bank for Oncology Board Prep • Percent correct provided on most questions to compare against the national average • Timed mode available to simulate exam conditions • Access from any computer or smartphone! • Also available: CME Redemption
Board Vitals

The University of Chicago Digestive Diseases Review: University of Chicago Medicine & Biological Sciences Specialty Review (SA-CME)

Studying the University of Chicago Digestive Diseases Review will help you to better: • Keep up with the latest advancements regarding the biology and treatment of patients with digestive diseases • Apply new knowledge in GI, hematology, and nutrition with this review in gastroenterology • Integrate current guidelines into daily practice when preventing and managing digestive diseases

Board Vitals Family Medicine MOC Re-Certification Question Bank and Review

Board Vitals Family Medicine MOC Re-Certification Question Bank and Review contains over 1500 ABFM and AOBFP Family Medicine MOC targeted review questions. The Board Vitals FM qbank offers questions that are directly relevant to the exam: multiple choice questions (mostly focused around patient scenarios) with a single best answer. Board Vitals Family Medicine MOC Re-Certification Question Bank Features: • Take the exam in review mode or timed mode to simulate real FM exam conditions • ...
Board Vitals

Board Vitals USMLE Step 2 Board Review Questions and Practice Tests

Board Vitals USMLE Step 2 Board Review Questions and Practice Tests • Over 1000 USMLE Step 2 Board Review Questions • 100% Pass Guarantee! • Higher Pass Rate Than The National Average • Individualized Learning Based on Performance
Board Vitals

Board Vitals USMLE Step 3 Board Review Questions

Board Vitals USMLE Step 3 Board Review Questions: • 1200 USMLE Step 3 board review questions • Individualized learning • Ability to flag questions for further review • Question are structured by category • Timed and review modes available • Detailed explanations associated with each question
Board Vitals

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.